Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner.

MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner. Cancer Res. 2006 May 15; 66(10):5104-10.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.